Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hemerson Guevara"'
Autor:
Hemerson Guevara, Beatrice Cenciu, Romain Blaizot, Kinan Drak Alsibai, Pierre Couppié, Magalie Demar, Jérôme Fayette, Marine Broly, Eve-Marie Neidhardt
Publikováno v:
International Journal of Dermatology
There are few studies available on melanoma in Afro‐Caribbean and Amerindian populations of South America. French Guiana deserves a study due to its specific health system and diversity of phototypes. The objectives of this study were to evaluate t
Autor:
Mathias Fehr, Jean-Damien Combes, Thibaut Reverdy, Olivier Tredan, Thibault De La Motte Rouge, S. Intidhar Labidi-Galy, Victoire de Castelbajac, Olfa Derbel, Lisa Golmard, Ketty Heimgartner-Hu, Pierre-Etienne Heudel, Valérie Bonadona, Valeria Viassolo, Manuel Rodrigues, Isabelle Ray-Coquard, Louise Crivelli, Hemerson Guevara, Anita Wolfer, Pauline Vaflard, Adrien Buisson, Fernando Bazan, Timothée Olivier, Elsa Kalbacher, Viola Heinzelmann-Schwarz
Publikováno v:
Translational Cancer Research
Objective To investigate clinical factors associated with prolonged progression-free survival (PFS) and overall survival (OS) in relapsing epithelial ovarian cancer (EOC) patients with BRCA mutations and receiving olaparib as maintenance therapy in d
Autor:
Hemerson Guevara, Valérie Bonadona, K. Hu-Heimgartner, Sana Intidhar Labidi-Galy, Pauline Vaflard, Louise Crivelli, V. de Castelbajac, Olivier Tredan, Olfa Derbel, Valeria Viassolo, Manuel Rodrigues, Viola Heinzelmann-Schwarz, I.L. Ray-Coquard, M. Fehr, Timothée Olivier, Elsa Kalbacher, Fernando Bazan, Jean-Damien Combes, T. deLa Motte Rouge, Anita Wolfer
Publikováno v:
Annals of Oncology. 30:v410
Background To investigate clinical factors associated with prolonged progression-free survival (PFS) and overall survival (OS) in relapsing epithelial ovarian cancer (EOC) patients with BRCA mutations and receiving olaparib as maintenance therapy in
Autor:
Adrien Buisson, Fernando Bazan, Timothée Olivier, Olivier Tredan, Valérie Bonadona, Elsa Kalbacher, Hemerson Guevara, Anita Wolfer, Ketty Hu, Jean-Damien Combes, Lisa Golmard, Victoire de Castelbajac, Thibault De La Motte Rouge, Sana Intidhar Labidi-Galy, Olfa Derbel, Valeria Viassolo, Manuel Rodrigues, Isabelle Ray-Coquard, Pauline Vaflard, Louise Crivelli
Publikováno v:
Journal of Clinical Oncology. 36:5558-5558
5558Background: To investigate clinical factors predictive for prolonged progression-free survival (PFS) in ovarian cancer (OC) patients carrying BRCA mutations and receiving olaparib as a maintena...